Hyperfine Inc (HYPR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $66.74M
Last updated: Nov 17, 2026 at 4:29 PM ET
Hyperfine Inc (HYPR) Statistics
Hyperfine (HYPR) has a market cap of $66.74M and an enterprise value of $42.22M. Its share count is up 34.27% from a year earlier. It kept -156.42% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 36.74% below the market cap, as cash exceeds debt.
| Market Cap | $66.74M |
|---|---|
| Enterprise Value | $42.22M |
| Latest price (Nov 17, 2026) | $0.56 |
Key Dates
| Last Earnings Date | Nov 9, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.1x and 1.9x. Its year-end P/S ranged from 4.9x to 8.7x from 2022 to 2025.
| P/S Ratio | 3.1x |
|---|---|
| Forward P/S | 3.3x |
| P/B Ratio | 1.9x |
Price Statistics
The stock is down 51.17% over 52 weeks and trades 27.27% below its 50-day average.
| Beta (1Y) | 1.94 |
|---|---|
| 52-Week Change | -51.17% |
| 1-Month Change | -27.74% |
| 3-Month Change | -37.72% |
| 6-Month Change | -60.17% |
| 5-Year Change | -92.81% |
| Total Return (1Y) | -51.17% |
| Total Return (3Y CAGR) | -23.20% |
| Total Return (5Y CAGR) | -43.75% |
| Max Drawdown (1Y) | -69.97% |
| Max Drawdown (3Y) | -74.47% |
| Sharpe Ratio (1Y) | -0.93 |
| Correlation with SPY (1Y) | 0.38 |
| 50-Day Average | $0.77 |
| 200-Day Average | $1.10 |
| 52-Week Range | $0.60 to $1.94 |
| RSI (14 Days) | 30.1 |
| Average Volume (20 Days) | 594.87K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.10x current liabilities, and total debt is 0.42x shareholder equity.
| Current Ratio | 5.10x |
|---|---|
| Quick Ratio | 4.50x |
| Debt / Equity | 0.42x |
Returns and Efficiency
Return on invested capital is -52.03% over the last 12 months, against a 5-year average of -70.51%.
| Return on Equity (ROE) | -93.92% |
|---|---|
| Return on Assets (ROA) | -51.59% |
| Return on Invested Capital (ROIC) | -52.03% |
| Return on Capital Employed (ROCE) | -62.84% |
| ROE (5Y Average) | -63.23% |
| ROA (5Y Average) | -53.42% |
| ROIC (5Y Average) | -70.51% |
| Asset Turnover | 0.38x |
| Inventory Turnover | 1.37x |
| Receivables Turnover | 3.10x |
| Cash Conversion Cycle | 301 days |
Scores
HYPR has an Altman Z-Score of -7.67, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -7.67 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $19.06M over the last 12 months is up 79.96% from the 12 months before.
| Revenue | $19.06M |
|---|---|
| Revenue Growth (YoY) | +79.96% |
| Gross Profit | $10.04M |
| Operating Income | -$31.95M |
| Pretax Income | -$29.81M |
| Net Income | -$29.81M |
| EBITDA | -$28.38M |
| EBIT | -$29.70M |
| Reported EPS (TTM) | -$0.33 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 54.92% of the $57.79M in total assets.
| Cash and Equivalents | $37.87M |
|---|---|
| Total Debt | $13.35M |
| Net Cash | $24.52M |
| Net Cash Per Share | $0.23 |
| Working Capital | $43.22M |
| Shareholder Equity | $31.74M |
| Book Value Per Share | $0.30 |
| Total Assets | $57.79M |
| Total Liabilities | $26.05M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $356.00K of capital spending, operating cash flow left -$27.92M of free cash flow.
| Operating Cash Flow | -$27.57M |
|---|---|
| Capital Expenditures | $356.00K |
| Free Cash Flow | -$27.92M |
| FCF Per Share | -$0.31 |
| Depreciation and Amortization | $1.32M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -167.64%.
| Gross Margin | 52.65% |
|---|---|
| Operating Margin | -167.64% |
| Pretax Margin | -156.42% |
| Net Margin | -156.42% |
| EBITDA Margin | -148.92% |
| EBIT Margin | -155.82% |
| FCF Margin | -146.50% |
| Gross Margin (5Y Average) | 14.78% |
Growth
Revenue grew 25.79% a year over 3 years.
| Revenue Growth (3Y CAGR) | +25.79% |
|---|---|
| Revenue Growth (5Y CAGR) | +115.18% |
| Book Value Per Share Growth (2Y CAGR) | -39.18% |
| Tangible Book Per Share Growth (2Y CAGR) | -39.18% |
Dividends and Yields
HYPR does not pay a dividend. Its free cash flow yield is -46.86%.
| FCF Yield | -46.86% |
|---|---|
| Buyback Yield | -55.71% |
| Shareholder Yield | -55.71% |
Peer Position
Against 11 similar companies, HYPR has the 5th highest P/S.
P/S RatioPeer median 1.3x
ROICPeer median -41.48%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +1.59%
| P/S Ratio | 3.1x vs 1.3x median |
|---|---|
| ROIC | -52.03% vs -41.48% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +79.96% vs +1.59% median |
Analyst Forecast
Consensus estimates put revenue growth at 41.10% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +41.10% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HYPR
What is HYPR's market cap?
Hyperfine has a market cap of $66.74M. Its enterprise value, which adds debt and subtracts cash, is $42.22M.
How many shares of HYPR are outstanding?
Hyperfine has 106.11M shares outstanding. The count is up 34.27% from a year earlier.
Does HYPR pay a dividend?
No. Hyperfine does not pay a dividend.
How much debt does HYPR have?
Hyperfine has $13.35M of total debt and $37.87M of cash and equivalents, a net cash position of $24.52M.
HYPR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors